Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 5926
115th Congress(2017-2018)
Naloxone Guidelines Act of 2018
Introduced
Introduced
Introduced in House on May 23, 2018
Overview
Text
Introduced in House 
May 23, 2018
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(May 23, 2018)
May 23, 2018
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 5926 (Introduced-in-House)


115th CONGRESS
2d Session
H. R. 5926


To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

May 23, 2018

Mr. Keating (for himself and Mr. Rothfus) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Naloxone Guidelines Act of 2018”.

SEC. 2. Guidelines for prescribing naloxone.

(a) In general.—Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidelines for prescribing an opioid overdose reversal drug.

(b) Contents.—In issuing guidelines under subsection (a), the Secretary shall address the following:

(1) Co-prescribing an opioid overdose reversal drug in conjunction with any prescribed opioid.

(2) Dosage safety.

(3) Prescribing an opioid overdose reversal drug to an individual other than a patient.

(4) Standing orders.

(5) Other distribution, education, and safety measures as determined necessary.